COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $184,000 | -9.4% | 11,480 | 0.0% | 0.01% | -22.2% |
Q2 2022 | $203,000 | -13.2% | 11,480 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $234,000 | +9.3% | 11,480 | 0.0% | 0.02% | +12.5% |
Q4 2021 | $214,000 | -5.7% | 11,480 | 0.0% | 0.02% | -11.1% |
Q3 2021 | $227,000 | -11.0% | 11,480 | +6.4% | 0.02% | +12.5% |
Q2 2021 | $255,000 | 0.0% | 10,793 | +0.1% | 0.02% | -11.1% |
Q1 2021 | $255,000 | +18.1% | 10,780 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $216,000 | -3.6% | 10,780 | 0.0% | 0.02% | -18.2% |
Q3 2020 | $224,000 | +14.9% | 10,780 | -3.1% | 0.02% | -18.5% |
Q2 2020 | $195,000 | +4.3% | 11,130 | -2.7% | 0.03% | 0.0% |
Q1 2020 | $187,000 | -19.7% | 11,442 | +1.0% | 0.03% | -3.6% |
Q4 2019 | $233,000 | +57.4% | 11,330 | -12.4% | 0.03% | +40.0% |
Q3 2019 | $148,000 | -12.9% | 12,930 | 0.0% | 0.02% | -20.0% |
Q2 2019 | $170,000 | -11.9% | 12,930 | +1.4% | 0.02% | -21.9% |
Q1 2019 | $193,000 | -11.9% | 12,750 | 0.0% | 0.03% | -23.8% |
Q4 2018 | $219,000 | – | 12,750 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,887,332 | $27,819,000 | 5.09% |
SECTORAL ASSET MANAGEMENT INC | 1,989,455 | $29,325,000 | 3.11% |
J. Goldman & Co LP | 1,581,885 | $23,317,000 | 1.63% |
Eventide Asset Management | 2,207,610 | $32,540,000 | 1.20% |
Rock Springs Capital Management LP | 1,650,100 | $24,322,000 | 0.88% |
HAMILTON LANE ADVISORS LLC | 114,489 | $2,000 | 0.81% |
RICE HALL JAMES & ASSOCIATES, LLC | 565,942 | $8,342,000 | 0.30% |
HIGHLAND CAPITAL MANAGEMENT LP | 337,429 | $4,973,000 | 0.27% |
Cortina Asset Management, LLC | 393,436 | $5,799,000 | 0.27% |
Cormorant Asset Management, LP | 250,000 | $3,685,000 | 0.24% |